2024-11-28: Speaker at Innovation Leaders Summit (ILS) 2024!
バイオテクノロジーで
未来を拓く
Unlocking future with Biotechnology
バイオテクノロジーで
未来を拓く
Unlocking future with Biotechnology
バイオテクノロジーで
未来を拓く
Unlocking future with Biotechnology
The PtBio Advantages
Feature
PtBio designs biological functions to address societal challenges.
As a platform provider leveraging cutting-edge biotechnology, we offer two integrated services tailored to our clients' needs:
-
Rapid Selection and Digital Breeding of Valuable Organisms via "Bio-DX"
-
Boosting Biological Performance through Precision "Genome Editing"
Takashi YAMAMOTO
YAMAMOTO, Takashi
The first president of the Japanese Society for Genome Editing, the top-runner in genome editing research in Japan.
He has promoted all-Japan industry-academia co-creation as the project leader of the COI-NEXT "Bio-DX Industry-Academia Co-Creation Center" and the head of the industry-academia co-creation consortium for the national project, OPERA "Genome Editing".
He is also a leading figure in genome editing, actively involved in developing advanced human resources in genome editing through the MEXT (Ministry of Education, Culture, Sports, Science and Technology) Excellence in Graduate Education Program.
Ranking of the number of publications in the world on genome editing
-2019 Nature Biotechnology 2nd in the world
-1st in the world in 2022 by Cells
Genome Editing
Our Initiatives
Projects
We collaborate with business partners across various industries to create high-value products that address societal challenges. As a growth engine for the biotechnology sector, we aim to drive the realization of a bioeconomy-based society.
Turning food waste into an effective resource
We are analyzing the bacterial flora of food waste and other fermented products by metagenome analysis, and are promoting initiatives aimed at effective utilization and high value-adding of unused organic materials that lead to food production based on resource recycling.
Improving efficiency of human waste treatment facilities with Bio-DX
In cooperation with the city of Higashi-Hiroshima, we are implementing the “Bio-DX” technology, which uses metagenome analysis to visualize the relationship between the seasonally fluctuating load and the microorganisms at the human waste treatment facility, with the aim of improving the facility's operating efficiency and reducing electricity consumption.
PtBio's Services
Service
We apply our proprietary Bio-DX and genome editing technology platforms across various industries to support problem-solving initiatives.
Technical Information
Tech Note
Technical information distributed by PtBio staff.
Company
PtBio Inc.
Location
3-10-23 Kagamiyama, Higashi-Hiroshima City, Hiroshima Prefecture, 739-0046, Japan
Capital Stock
253.65 million yen
Establishment
August 30, 2019
Officer
CEO: Keisuke Okuhara
Director: Takashi Yamamoto
Outside Director: Koji Taniguchi
Auditor: Hiroki Umenaka
Employees
Number of employees: 31 (as of August 1, 2024)